Artiva Biotherapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Artiva Biotherapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $26.70 million for the year ending 2025.

  • Artiva Biotherapeutics, Inc. showed a decrease of -33.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Artiva Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Artiva Biotherapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 50.1%.
  • Historical annual values: Fiscal year 2025: $26.70 million | Fiscal year 2024: $40.24 million | Fiscal year 2023: $53.50 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: